July 2, 2021

BOSTON and DURHAM, N.C., July 02, 2021 (GLOBE NEWSWIRE) — Parexel, a leading global clinical research organization (CRO) focused on

Mont-Saint-Guibert, Belgium – July 2, 2021, 2:40pm CET / 8:40am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”),

Philogen Announces R&D Program Update Fibromun shows activity in pretreated glioma and sarcoma patients; OncoFAP targets tumor lesions in cancer

SHANGHAI, China, July 02, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated

Nguyen Hai CHICAGO, July 01, 2021 (GLOBE NEWSWIRE) — As part of its commitment to help producers meet the growing

Seattle, July 01, 2021 (GLOBE NEWSWIRE) — AGC Biologics, a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced